testosterone

Male hypogonadism: a review
Marco Marcelli, Sanjay Navin Mediwala

Journal of Investigative Medicine Feb 2020, 68 (2) 335-356; DOI: 10.1136/jim-2019-001233
Traditional signs and symptoms commonly attributed to hypogonadism do not correlate with testosterone levels: the Cooper Center Longitudinal Study Experience
Laura F DeFina, Nina B Radford, David Leonard, Rick K Wilson, Tyler C Cooper, S Michael Clark, Gloria Lena Vega, Carolyn E Barlow, Benjamin L Willis, Larry W Gibbons, Ugis Gruntmanis

Journal of Investigative Medicine Feb 2020, 68 (2) 378-382; DOI: 10.1136/jim-2019-001083
Thromboembolism peaking 3 months after starting testosterone therapy: testosterone–thrombophilia interactions
Charles J Glueck, Naila Goldenberg, Ping Wang

Journal of Investigative Medicine Apr 2018, 66 (4) 733-738; DOI: 10.1136/jim-2017-000637
Testosterone treatment and cardiovascular and venous thromboembolism risk: what is ‘new’?
G Corona, M Dicuio, G Rastrelli, E Maseroli, F Lotti, A Sforza, M Maggi

Journal of Investigative Medicine Aug 2017, 65 (6) 964-973; DOI: 10.1136/jim-2017-000411
Assessment of Serum Chromogranin-A as Prognostic Factor in High-Risk Prostate Cancer
Leonardo O. Reis, Larissa F.M. Vieira, Emerson L. Zani, Fernandes Denardi, Laurione C. de Oliveira, Ubirajara Ferreira

Journal of Investigative Medicine Dec 2010, 58 (8) 957-960; DOI: 10.2310/JIM.0b013e3181f5d610
The 5α-Androstanedione Pathway to Dihydrotestosterone in Castration-Resistant Prostate Cancer
Nima Sharifi

Journal of Investigative Medicine Feb 2012, 60 (2) 504-507; DOI: 10.2310/JIM.0b013e31823874a4
Comparison of Testosterone, Alendronate, and a Combination of Both Therapies in Men with Low Bone Mineral Density
Brian J. Welch, Margo A. Denke, Asra Kermani, Beverley Adams-Huet, Nina M. Gazmen, Ugis Gruntmanis

Journal of Investigative Medicine May 2007, 55 (4) 168-173; DOI: 10.2310/6650.2007.06047

Log in using your username and password

Main menu

Log in using your username and password

You are here

testosterone